Allarity Therapeutics, Inc. (ALLR) › EBITDAAllarity Therapeutics, Inc. (ALLR): EBITDAOperating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.-$27.23MYear ended 2024-12-312020-12-31: -$8.27M2021-12-31: -$26.45M2022-12-31: -$34.40M2023-12-31: -$17.09M2024-12-31: -$27.23M-$27.23M2020-12-31 EBITDA (USD) 2024-12-31Period endedEBITDAChange YoYSource filing2024-12-31-$27.23Mn/m2026-03-30, From 2024-01-012023-12-31-$17.09Mn/m2025-03-31, From 2023-01-012022-12-31-$34.40Mn/m2024-03-08, From 2022-01-012021-12-31-$26.45Mn/m2023-03-13, From 2021-01-012020-12-31-$8.27Mn/a2022-05-17, From 2020-01-01Other metrics: RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesLong-Term DebtShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesShares OutstandingWeighted Average Diluted SharesEPS (Basic)